New therapeutic approaches to sickle cell disease: Targeting RBC membrane oxidative damage

S. R. Goodman, Betty Sue Pace, A. Shartava

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

In this brief review, we discuss evidence leading to the conclusion that diminished levels of reduced glutathione combined with increased oxygen radical production leads to oxidative damage to membrane proteins in sickle cell disease erythrocytes. Among these oxidatively damaged proteins are K+- channels (Gardos channel and K+-Cl--channel) and β-actin. Oxidative damage to the K+-channels leads to K+ leakage and H2O loss from light density reversibly sickled cells (RSCs). The resulting dense RSCs are primarily sickled in shape due to increased [HbS] and increased polymerization. The oxidation of β-actin converts the dense RSCs to dense irreversibly sickled cells (ISCs) as explained in our two step model. Furthermore, we discuss recent in vitro evidence that N-acetylcysteine (NAC) can block the formation of dense cells and ISCs by protecting the K+-channels and β-actin respectively from oxidative damage. Finally we describe an ongoing Phase II human trial to determine whether NAC can also lower dense cells and ISCs in vivo and, if so, result in fewer painful vasooclusive episodes.

Original languageEnglish (US)
Pages (from-to)403-411
Number of pages9
JournalCellular and Molecular Biology Letters
Volume3
Issue number4
StatePublished - Jan 1 1998
Externally publishedYes

Fingerprint

Sickle Cell Anemia
Actins
Acetylcysteine
Membranes
Glutathione
Reactive Oxygen Species
Membrane Proteins
Therapeutics
Polymerization
Cells
Oxidation
Erythrocytes
Light

Keywords

  • Dense Cells
  • Drug Therapy
  • Glutathione
  • Irreversibly Sickled Cells
  • N-acetylcysteine
  • Sickle Cell Disease
  • Spectrin
  • β-actin

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

New therapeutic approaches to sickle cell disease : Targeting RBC membrane oxidative damage. / Goodman, S. R.; Pace, Betty Sue; Shartava, A.

In: Cellular and Molecular Biology Letters, Vol. 3, No. 4, 01.01.1998, p. 403-411.

Research output: Contribution to journalArticle

@article{8c0ca5d81acf49b1a89fa38935703a9b,
title = "New therapeutic approaches to sickle cell disease: Targeting RBC membrane oxidative damage",
abstract = "In this brief review, we discuss evidence leading to the conclusion that diminished levels of reduced glutathione combined with increased oxygen radical production leads to oxidative damage to membrane proteins in sickle cell disease erythrocytes. Among these oxidatively damaged proteins are K+- channels (Gardos channel and K+-Cl--channel) and β-actin. Oxidative damage to the K+-channels leads to K+ leakage and H2O loss from light density reversibly sickled cells (RSCs). The resulting dense RSCs are primarily sickled in shape due to increased [HbS] and increased polymerization. The oxidation of β-actin converts the dense RSCs to dense irreversibly sickled cells (ISCs) as explained in our two step model. Furthermore, we discuss recent in vitro evidence that N-acetylcysteine (NAC) can block the formation of dense cells and ISCs by protecting the K+-channels and β-actin respectively from oxidative damage. Finally we describe an ongoing Phase II human trial to determine whether NAC can also lower dense cells and ISCs in vivo and, if so, result in fewer painful vasooclusive episodes.",
keywords = "Dense Cells, Drug Therapy, Glutathione, Irreversibly Sickled Cells, N-acetylcysteine, Sickle Cell Disease, Spectrin, β-actin",
author = "Goodman, {S. R.} and Pace, {Betty Sue} and A. Shartava",
year = "1998",
month = "1",
day = "1",
language = "English (US)",
volume = "3",
pages = "403--411",
journal = "Cellular and Molecular Biology Letters",
issn = "1425-8153",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - New therapeutic approaches to sickle cell disease

T2 - Targeting RBC membrane oxidative damage

AU - Goodman, S. R.

AU - Pace, Betty Sue

AU - Shartava, A.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - In this brief review, we discuss evidence leading to the conclusion that diminished levels of reduced glutathione combined with increased oxygen radical production leads to oxidative damage to membrane proteins in sickle cell disease erythrocytes. Among these oxidatively damaged proteins are K+- channels (Gardos channel and K+-Cl--channel) and β-actin. Oxidative damage to the K+-channels leads to K+ leakage and H2O loss from light density reversibly sickled cells (RSCs). The resulting dense RSCs are primarily sickled in shape due to increased [HbS] and increased polymerization. The oxidation of β-actin converts the dense RSCs to dense irreversibly sickled cells (ISCs) as explained in our two step model. Furthermore, we discuss recent in vitro evidence that N-acetylcysteine (NAC) can block the formation of dense cells and ISCs by protecting the K+-channels and β-actin respectively from oxidative damage. Finally we describe an ongoing Phase II human trial to determine whether NAC can also lower dense cells and ISCs in vivo and, if so, result in fewer painful vasooclusive episodes.

AB - In this brief review, we discuss evidence leading to the conclusion that diminished levels of reduced glutathione combined with increased oxygen radical production leads to oxidative damage to membrane proteins in sickle cell disease erythrocytes. Among these oxidatively damaged proteins are K+- channels (Gardos channel and K+-Cl--channel) and β-actin. Oxidative damage to the K+-channels leads to K+ leakage and H2O loss from light density reversibly sickled cells (RSCs). The resulting dense RSCs are primarily sickled in shape due to increased [HbS] and increased polymerization. The oxidation of β-actin converts the dense RSCs to dense irreversibly sickled cells (ISCs) as explained in our two step model. Furthermore, we discuss recent in vitro evidence that N-acetylcysteine (NAC) can block the formation of dense cells and ISCs by protecting the K+-channels and β-actin respectively from oxidative damage. Finally we describe an ongoing Phase II human trial to determine whether NAC can also lower dense cells and ISCs in vivo and, if so, result in fewer painful vasooclusive episodes.

KW - Dense Cells

KW - Drug Therapy

KW - Glutathione

KW - Irreversibly Sickled Cells

KW - N-acetylcysteine

KW - Sickle Cell Disease

KW - Spectrin

KW - β-actin

UR - http://www.scopus.com/inward/record.url?scp=0032446113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032446113&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0032446113

VL - 3

SP - 403

EP - 411

JO - Cellular and Molecular Biology Letters

JF - Cellular and Molecular Biology Letters

SN - 1425-8153

IS - 4

ER -